Cargando…
Author Correction: Farnesoid X receptor activation inhibits TGFBR1/TAK1-mediated vascular inflammation and calcification via miR-135a-5p
Autores principales: | Li, Chao, Zhang, Shijun, Chen, Xiaoqing, Ji, Jingkang, Yang, Wenqing, Gui, Ting, Gai, Zhibo, Li, Yunlun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648068/ https://www.ncbi.nlm.nih.gov/pubmed/33159129 http://dx.doi.org/10.1038/s42003-020-01414-1 |
Ejemplares similares
-
Farnesoid X receptor activation inhibits TGFBR1/TAK1-mediated vascular inflammation and calcification via miR-135a-5p
por: Li, Chao, et al.
Publicado: (2020) -
Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
por: Li, Chao, et al.
Publicado: (2020) -
Author Correction: Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1/2 pathway
por: Singh, Kanika, et al.
Publicado: (2020) -
Antioxidant Effects of Protocatechuic Acid and Protocatechuic Aldehyde: Old Wine in a New Bottle
por: Zhang, Shijun, et al.
Publicado: (2021) -
TAK1 safeguards endothelial cells from gut microbes and inflammation
por: Naito, Hisamichi, et al.
Publicado: (2019)